| Entry |
|
|---|
| Name |
Acyclovir sodium (USAN);
Zovirax (TN) |
|---|
| Product |
|
|---|
| Generic |
|
|---|
| Formula |
C8H10N5O3. Na
|
|---|
| Exact mass |
247.0681
|
|---|
| Mol weight |
247.1865
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Antiviral
DG02840 Anti-herpesvirus agent
Transporter substrate
DG02858 SLC22A1 substrate
DG02859 SLC22A6 substrate
DG02860 SLC22A8 substrate
|
|---|
| Remark |
| Product (DG00406): | D00222<JP/US> D02764<US> |
|
|---|
| Efficacy |
Antiviral, DNA polymerase inhibitor |
|---|
| Disease |
Herpes simplex infection [DS: H00365] Varicella-zoster infections [DS: H00366] |
|---|
| Target |
Herpesvirus DNA polymerase [KO: K18964] |
|---|
| Pathway |
|
|---|
| Metabolism |
Transporter: SLC22A1 [HSA: 6580], SLC22A6 [HSA: 9356], SLC22A8 [HSA: 9376]
|
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
D DERMATOLOGICALS
D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE
D06B CHEMOTHERAPEUTICS FOR TOPICAL USE
D06BB Antivirals
D06BB03 Aciclovir
D02764 Acyclovir sodium (USAN) <US>
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
J05AB01 Aciclovir
D02764 Acyclovir sodium (USAN) <US>
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01A ANTIINFECTIVES
S01AD Antivirals
S01AD03 Aciclovir
D02764 Acyclovir sodium (USAN) <US>
USP drug classification [BR:br08302]
Antivirals
Antiherpetic Agents
Acyclovir
D02764 Acyclovir sodium (USAN)
Dermatological Agents
Topical Anti-infectives
Antivirals, dermatological
Acyclovir
D02764 Acyclovir sodium (USAN)
Risk category of Japanese OTC drugs [BR:br08312]
First-class OTC drugs
Inorganic and organic chemicals
Aciclovir
D02764 Acyclovir sodium (USAN)
Drug groups [BR:br08330]
Antiviral
DG02840 Anti-herpesvirus agent
DG00406 Aciclovir
D02764 Acyclovir sodium
Transporter substrate
DG02858 SLC22A1 substrate
DG00406 Aciclovir
D02764 Acyclovir sodium
DG02859 SLC22A6 substrate
DG00406 Aciclovir
D02764 Acyclovir sodium
DG02860 SLC22A8 substrate
DG00406 Aciclovir
D02764 Acyclovir sodium
Drug classes [BR:br08332]
Antiviral
DG02840 Anti-herpesvirus agent
D02764 Acyclovir sodium
Antimicrobials [BR:br08307]
Antivirals
Genome replication inhibitor
Herpesvirus DNA polymerase inhibitor
D02764 Acyclovir sodium (USAN) <US>
Drug metabolizing enzymes and transporters [br08309.html]
Drug transporters
D02764
Drug groups [BR:br08330]
Antiviral
DG02840 Anti-herpesvirus agent
DG00406 Aciclovir
Transporter substrate
DG02858 SLC22A1 substrate
DG00406 Aciclovir
DG02859 SLC22A6 substrate
DG00406 Aciclovir
DG02860 SLC22A8 substrate
DG00406 Aciclovir
Antimicrobials abbreviations [BR:br08327]
Antivirals
Genome replication inhibitor
Herpesvirus DNA polymerase inhibitor
DG00406 Aciclovir
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 17
1 C8y C 20.2300 -29.1200
2 C8y C 20.2300 -30.5200
3 N5x N 21.4424 -31.2200
4 C8y C 22.6549 -30.5200
5 N4x N 22.6549 -29.1200 #-
6 C8y C 21.4424 -28.4200
7 N1a N 23.8860 -31.2310
8 O5x O 21.4424 -27.0202
9 N5x N 18.8985 -28.6874
10 C8x C 18.0756 -29.8200
11 N4y N 18.8985 -30.9526
12 C1b C 18.8985 -32.3526
13 O2a O 17.6927 -33.0488
14 C1b C 16.4896 -32.3540
15 C1b C 15.3060 -33.0372
16 O1a O 14.1129 -32.3481
17 Z Na 24.4300 -29.1200 #+
BOND 17
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 1
6 1 6 1
7 4 7 1
8 6 8 2
9 1 9 1
10 9 10 2
11 10 11 1
12 2 11 1
13 11 12 1
14 12 13 1
15 13 14 1
16 14 15 1
17 15 16 1
|
|---|
